Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
COVID-19 results from SARS-CoV-2, which mutates frequently, challenging current treatments. Therefore, it is critical to develop new therapeutic drugs against this disease. This study explores the interaction between SARS-CoV-2 3CLpro and RetroMAD1, a well-characterized coronavirus protein and poten...
保存先:
主要な著者: | Chan, Lee-Chin, Mat Yassim, Aini Syahida, Ahmad Fuaad, Abdullah Al Hadi, Leow, Thean Chor, Sabri, Suriana, Radin Yahaya, Radin Shafierul, Abu Bakar, Awang Muhammad Sagaf |
---|---|
フォーマット: | 論文 |
出版事項: |
Nature Research
2023
|
オンライン・アクセス: | http://psasir.upm.edu.my/id/eprint/110356/ https://www.nature.com/articles/s41598-023-47511-z?error=cookies_not_supported&code=c6e450e7-4bbd-44af-ad7c-a9ed05a4a4fe |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Pathophysiology, histopathology and therapeutic of SARS-CoV-2
著者:: Noman, Efaq, 等
出版事項: (2020) -
Survival and disinfection of SARS-Cov-2 in environment and contaminated surface
著者:: Al-Gheethi, Adel, 等
出版事項: (2020) -
Molecular docking unveils prospective inhibitors for the SARS-COV-2 main protease
著者:: Ahmad, Fawad, 等
出版事項: (2021) -
Fragment-based in silico design of SARS-CoV-2 main protease inhibitors
著者:: Ahmad, Sarfraz, 等
出版事項: (2021) -
Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
著者:: Somboon, Tuanjai, 等
出版事項: (2021)